Gadoteridol Injectable Solution 0.5 mol/L Suppliers & Bulk Manufacturers

Available Forms: Injectable Solution

Available Strengths: 0.5 mol/L

Reference Brands: ProHance(US & EU)

Category: Contrast Agent

Gadoteridol is a gadolinium-based contrast agent that enhances MRI images by increasing tissue radiopacity. It improves visualization of blood vessels, organs, and abnormalities, supporting accurate diagnosis. Benefits include high image clarity, rapid clearance, safety, and detailed imaging that aids effective neurological, cardiovascular, and musculoskeletal assessments worldwide.

Product Description: Gadoteridol injectable solution, marketed as ProHance, is approved in the US by the FDA and in the EU via EMA for MRI contrast enhancement. Regulatory approval requires comprehensive dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures compliance with regional safety and manufacturing regulations. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports swift approval, safe administration, and worldwide availability, enabling high-quality diagnostic imaging for neurological, cardiovascular, and musculoskeletal assessments globally.